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Sulﬁde salts are known to promote the release of nitric oxide (NO) from S-nitrosothiols and potentiate
their vasorelaxant activity, but much of the cross-talk between hydrogen sulﬁde and NO is believed to
occur via functional interactions of cell regulatory elements such as phosphodiesterases. Using RFL-6
cells as an NO reporter system we sought to investigate whether sulﬁde can also modulate nitrosothiol-
mediated soluble guanylyl cyclase (sGC) activation following direct chemical interaction. We ﬁnd a
U-shaped dose response relationship where low sulﬁde concentrations attenuate sGC stimulation by
S-nitrosopenicillamine (SNAP) and cyclic GMP levels are restored at equimolar ratios. Similar results are
observed when intracellular sulﬁde levels are raised by pre-incubation with the sulﬁde donor, GYY4137.
The outcome of direct sulﬁde/nitrosothiol interactions also critically depends on molar reactant ratios
and is accompanied by oxygen consumption. With sulﬁde in excess, a ‘yellow compound’ accumulates
that is indistinguishable from the product of solid-phase transnitrosation of either hydrosulﬁde or
hydrodisulﬁde and assigned to be nitrosopersulﬁde (perthionitrite, SSNO; λmax 412 nm in aqueous
buffers, pH 7.4; 448 nm in DMF). Time-resolved chemiluminescence and UV–visible spectroscopy
analyses suggest that its generation is preceded by formation of the short-lived NO-donor, thionitrite
(SNO). In contrast to the latter, SSNO is rather stable at physiological pH and generates both NO and
polysulﬁdes on decomposition, resulting in sustained potentiation of SNAP-induced sGC stimulation.
Thus, sulﬁde reacts with nitrosothiols to form multiple bioactive products; SSNO rather than SNO may
account for some of the longer-lived effects of nitrosothiols and contribute to sulﬁde and NO signaling.
& 2014 The Authors. Published by Elsevier B.V. All rights reserved.
Introduction
Hydrogen sulﬁde (H2S), known as a noxious malodorous gas of
volcanic and biogenic origin for centuries, has recently been
shown to exert a multitude of beneﬁcial biological effects, some
of which have therapeutic potential [1,2]. Pharmacological doses
of simple sulﬁde salts have been demonstrated to protect tissues
against ischemia-reperfusion injury [3,4]. Endogenous sulﬁde
production appears to be involved in the physiological modulation
of numerous cellular processes in almost every organ system,
including control of vascular tone and blood pressure regulation
[4]. It has been suggested that H2S should be recognized as a third
‘gasotransmitter’, alongside nitric oxide (NO) and carbon mon-
oxide [5,6], although this is not unanimously accepted [7].
In physiological systems, only a small part of H2S actually exists
in the form of dissolved gas. As a diprotic weak acid (mean
pKa1¼7.0 and pKa2412 at 25 1C [8]), H2S rapidly deprotonates
to form hydrosulﬁde anions (HS) with negligible amounts of
S2 existing at physiological pH [8]. The relative amounts of the
three species at equilibrium depend on temperature, pH, ionic
strength, amount of H2S gas leaving the solution, as well as “side”
reactions including sulﬁde oxidation to form sulﬁte, sulfate, and
thiosulfate, and polymerization reactions generating polysulﬁdes
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and polythionates. These products themselves are characterized
by complex ionization equilibria which may affect solution pH and
thus concentrations of HS and dissolved H2S [8,9]. For simplicity,
all three forms co-existing in equilibrium (H2S, HS , and S2) will
hereinafter be referred to as ‘sulﬁde’.
Striking similarities between some of the effects of NO and
sulﬁde, in particular with regard to their role in control of vascular
tone and blood pressure regulation, together with interesting
mutual regulatory effects, raised the possibility of a cross-talk
between these species [10–18]. Peculiarly, pharmacological appli-
cation of sulﬁde was shown to induce both vasodilation [19] and
vasoconstriction [10] ex vivo, and both hypotensive and hyperten-
sive effects have been described in vivo [10,19]. Wang surmised
that the effects of sulﬁde may depend on the speciﬁc vascular bed
(conductance vs. resistance vessels), cell type (endothelial vs.
smooth muscle cells), concentration of sulﬁde and presence or
absence of NO/nitric oxide synthase in a particular experimental
setting [20]. Moore et al. [10,21,22] proposed that vasoconstriction
and hypertensive effects of lower sulﬁde doses were due to a
direct chemical interaction between vascular NO and sulﬁde
leading the formation of an intermediate, which was susceptible
to destruction by addition of transition metals. These authors
hypothesized that this intermediate might be a “nitrosothiol”,
probably thionitrous acid (HSNO) [21].
HSNO was described by Williams as the obvious product of
sulﬁde nitrosation [23]; likewise, HSNO is the obvious product of
the reaction between HS and nitrosothiols. Indeed, a recent
report suggests that HSNO is formed by direct reaction of S-
nitrosoglutathione (GSNO) with sulﬁde in phosphate buffer at pH
7, and is stable enough to transport NO intermediates across cell
membranes [24]. In contrast, earlier reports found this compound
to be unstable and reactive, necessitating characterization of its
isomerization properties to be carried out in a low temperature
argon matrix [25].
The reaction between sulﬁde and S-nitrosothiols has been
shown to promote NO release, potentiating their vasorelaxant
activity in aortic rings [26] and allowing for nitrosothiol quantiﬁ-
cation by gas phase chemiluminescence [27]. It is not clear at
present whether these effects of sulﬁde are due to post-
translational modiﬁcation of vascular proteins, accelerated nitro-
sothiol decomposition, formation of NO-generating intermediates,
or a combination of these putative mechanisms [17,18]. Indepen-
dent of the above chemical studies, a recent report suggests that
much of the H2S/NO cross-talk might occur by modulation of cyclic
nucleotide breakdown following inhibition of phosphodiesterase
(PDE) activity [28].
The aim of the present study was to investigate whether sulﬁde
can modulate S-nitrosothiol-mediated activation of the NO recep-
tor soluble guanylyl cyclase (sGC) in a simple cellular system that
lacks an endogenous NO production machinery and expresses low
levels of PDE5 [29]. We found that sulﬁde modulates nitrosothiol
bioactivity in a concentration-dependent manner. Under condi-
tions of excess sulﬁde, a ‘yellow compound’ accumulates that has
the potential to spontaneously release NO and activate sGC. We
assign this species to be nitrosopersulﬁde (SSNO) and propose
that this reaction product, rather than HSNO, is the main carrier of
sustained NO bioactivity following interaction of sulﬁde with
nitrosothiols.
Materials and methods
Materials
Ultrapure water (Milli-Q, Millipore), S-nitroso-N-acetyl-DL-peni-
cillamine (SNAP), sodium persulﬁde (Na2S2, sodium disulﬁde; Sage
Chemical Co., Ltd, Hangzhou, China), p-methoxyphenyl-morpholino-
phosphinodithioic acid (GYY4137), 3-isobutyl-1-methylxanthine
(IBMX) and 30-methoxy-3-oxo-3H-spiro[isobenzofuran-1,90-xanthen]-
60-yl 2-(pyridin-2-yldisulfanyl)benzoate (Washington State Probe-1,
WSP-1) from Cayman Chemicals (Biomol, Hamburg, Germany) was
used. Unless otherwise speciﬁed, all other chemicals were of the
highest purity available and purchased from Sigma-Aldrich (Schnell-
dorf, Germany or Gillingham, Dorset, UK), cell culture plastics from
Greiner (Frickenhausen, Germany), and other cell culture material
from PAA (Pashing, Austria). Fetal bovine serum (FBS) was from
Cambrex (Lonza, Cologne, Germany).
Cell culture
Rat ﬁbroblastoid-like (RFL-6, ATCC CCL192™) cells were pur-
chased from LGC Standards GmbH (Wesel, Germany) and cultured
from passage 8–18 in T9 ﬂasks using RPMI 1640, supplemented
with 20% fetal bovine serum and antibiotics in a CO2 incubator
under standard cell culture conditions.
Preparation of stock solutions and RSNO/sulﬁde mixtures
Stock solutions of SNAP (100 mM, DMSO or DMF), IBMX
(50 mM, DMSO), GYY4137 stocks (40 mM, DMSO), and WSP-1
(5 mM, DMSO) were kept aliquoted at 20 1C until use. Stock
solutions of S-nitrosocysteine (CysNO) and S-nitrosoglutathione
(GSNO) were freshly prepared via reaction of the reduced thiols
with acidiﬁed nitrite [30] and used immediately. Na2S stock
solutions (200 mM) were prepared fresh before each experiment
by dissolving anhydrous Na2S in a strong buffer (TRIS or phosphate
buffer 1 M at pH 7.4) and diluted further in 100 mM TRIS or
phosphate buffer pH 7.4 immediately before use. Incubation
mixtures of nitrosothiols with Na2S were obtained by adding
appropriate volumes of the stock solutions directly to the incuba-
tion buffer to achieve ﬁnal concentrations of 1 mM for the
nitrosothiol and 0.2–10 mM for sulﬁde, as indicated in text and
ﬁgures.
Measurements of sGC activation by sulﬁde, SNAP, and its mixtures
sGC activity was estimated by measurement of intracellular
cGMP levels of RFL-6 reporter cells as described [31], with minor
modiﬁcations. Brieﬂy, 1.5105 cells/well were seeded into 6-well
plates, grown for 48 h until conﬂuence, washed twice with 1 ml
phosphate buffered saline (PBS; pre-warmed to 37 1C), and pre-
treated for 15 min with the PDE inhibitor IBMX (500 mM) in
culture medium without serum (treatment medium). After wash-
ing with PBS, 1 ml fresh treatment medium was added and cells
were then treated as indicated. In this system, SNAP and other
NO-donors cause concentration-dependent increases in intracel-
lular cGMP, which are fully inhibited by NO-scavengers (Fig. 1 and
Fig. S1). To capture a wide-enough time window for NO bioactivity
measurements, all SNAP/sulﬁde incubations were carried out for
30 min (during which time SNAP-induced cGMP elevations
remained relatively constant; Fig. S1A). In a ﬁrst set of experi-
ments, SNAP and immediately thereafter Na2S (or the vehicle
controls) were added directly to the treatment medium at the
concentrations indicated. In a second set of experiments, RFL-6
cells were pre-incubated with GYY4137 for 45 min, washed and
then treated with SNAP. In a third set of experiments, stock
solutions of nitrosopersulﬁde (SSNO) were prepared by reacting
1 mM SNAP with 10 mM Na2S in 1 ml PBS or TRIS 100 mM pH 7.4.
In a typical experiment, 10 ml of SNAP (100 mM/DMSO) and 100 ml
Na2S (100 mM/Tris 100 mM pH 7.4) were added to an amber
centrifugation tube containing 890 ml Tris 100 mM pH 7.4. After
10 min of incubation at RT, excess sulﬁde was removed either by
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precipitation with ZnCl2 (20 ml of 500 mM ZnCl2 to 1 ml yellow
mixture; ﬁnal concentration 10 mM), followed by a 1 min centri-
fugation at maximal speed, or by 10 min bubbling of the solution
with nitrogen. Removal of sulﬁde was veriﬁed spectrophotome-
trically. The mix (2 ml, 20 ml, 200 ml) was then added to cell culture
medium to reach a total volume of 1 ml (corresponding to a 1:500;
1:50; 1:5 dilution). In selected experiments, an sGC inhibitor
(ODQ, 500 mM) or an NO scavenger (cPTIO, 500 mM) were added
5 min prior to the addition of sulﬁde and/or SNAP. The above
dilution steps bring the theoretical maximal concentration of NO-
containing bioactive material into the micromolar range. No signs
of cell toxicity were observed following either of these treatments,
as assessed by micro/macroscopic cell inspection and determina-
tion of protein content; the latter would have been reduced if a
signiﬁcant number of apoptotic/dead cells detached from the
plates.
Cells were lysed in 0.1 M HCl at RT for 20 min, scraped,
sonicated twice for 30 s at 4 1C, centrifuged at 30,000g for
10 min at 4 1C to remove cell debris, and the supernatant snap-
frozen in liquid N2 and kept at 80 1C until analysis. Protein
concentrations in the supernatant were determined by a modiﬁed
Bradford’s protein assay (RotisNanoquant, Carl Roth GmbHþCo.
KG, Karlsruhe, Germany) after pH equilibration with 200 mM TRIS
pH 8. Intracellular cGMP levels were assessed by using DetectX-
sHigh Sensitivity Direct Cyclic GMP kit by Arbor Assay (Biotrend,
Cologne, Germany) as per manufacturer’s instructions. Data were
normalized for protein content and expressed as pmoles/ml/mg
protein or as ratios compared to untreated cells. Changes in
intracellular cGMP levels, normalized for protein content, were
expressed as % of untreated control to further account for the
variability in basal cGMP levels of untreated cells of different
batches and passages (Fig. S1A, insert).
Determination of intracellular sulﬁde levels
Intracellular sulﬁde levels were determined by ﬂow cytometry
following loading of RFL-6 cells with 10 mM WSP-1 for 30 min.
After washing with 1 ml pre-warmed PBS, cells were detached by
addition of 2 ml Accutases (PAA), and intracellular green ﬂuores-
cence (λex 488 nm, λem 519 nm) was assessed in a FACS-Verse ﬂow
cytometer (BD Bioscience, Heidelberg, Germany). Data were cal-
culated as median ﬂuorescence intensity (MFI) of loaded cells –
background (ΔMFI) by plotting side-scatter (SSC) vs. ﬂuorescence
intensity in the FITC channel using FlowJo 10.0.6 (Tristar, Ashland,
OR, USA).
Measurement of phopshodiesterase activity
RFL-6 cells cultured for 10 or 18 passages, were scraped, lyzed
in homogenization buffer (triethanolamine (TEA)/HCl 50 mM, NaCl
50 mM, EDTA 1 mM, DTT 2 mM, benzamidine 0.2 mM, phenyl-
methylsulfonyl ﬂuoride 0.5 mM and 1 mM pepstatin A, pH 7.4,
4 1C), and cleared by centrifugation (800 g, 5 min, 4 1C). PDE
activity in cell homogenates was measured by the conversion of
[32P]cGMP or [32P]cAMP (synthesized from [α-32P]GTP or [32P]ATP
using puriﬁed NO-sensitive guanylyl or adenylyl cyclase) to gua-
nosine or adenosine and [32P]phosphate in the presence of alka-
line phosphatase at 37 1C for 7 min. Reaction mixtures (0.1 ml)
contained 0.05–10 ml of the homogenates (5 mg protein), [32P]
cGMP or [32P]cAMP (2 kBq), various cGMP concentrations (0.1, 1,
or 5 mM), 12 mM MgCl2, 3 mM dithiothreitol, 0.5 mg/ml bovine
serum albumin, 2 or 4 U of alkaline phosphatase, and 50 mM
TEA/HCl, pH 7.4. Reactions were stopped by adding 900 ml ice cold
charcoal suspension (30% activated charcoal in 50 mM KH2PO4,
pH 2.3). After pelleting the charcoal by centrifugation, [32P]
Fig. 1. Sulﬁde modulates s-nitrosothiol bioactivity in a concentration-dependent manner. (A) Changes in cGMP concentration after treatment of RFL-6 cells with Na2S, SNAP,
or their combination (n¼5). (B) Effects of SNAP on cells pre-incubated with the sulﬁde donor GYY4137 (n¼4). (C) Effects of sGC and PDE inhibition on Na2S and GYY4137
induced activation of sGC (n¼4). (D) Effects of cPTIO on sulﬁde and SNAP induced sGC activation (n¼3) n po0.05; nn po0.01 vs. CTRL, # po0.05, T-test.
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phosphate in the supernatant was quantiﬁed by scintillation
counting.
Reaction of sulﬁde with nitrosothiols
The spectroscopic and kinetic behavior of the reaction between
sulﬁde and CysNO, GSNO and SNAP was followed by UV–visible
spectroscopy in a FLUOstar Omega (BMG Labtech, Offenburg,
Germany). Stock solutions (100 mM) were diluted 1:100 in 1 M
TRIS pH 7.5, transferred to a UV-transparent 96-well plate (200 ml/
well). The in-built automatic injector was ﬁlled with 50 mM Na2S
solution for in-well titration experiments. Spectra (200–800 nm)
were acquired before and every 2 s for 100 cycles after injection of
1–20 ml aliquots of Na2S. Spectra were analyzed using Omega data
analysis software (BMG Labtech). All other studies were carried
out in 3 ml-volume quartz cuvettes, kept at either 25.0 or
37.070.02 1C with continuous stirring (t2 peltier-type cuvette
holder with TC1 temperature controller, Quantum Northwest,
Liberty Lake, WA, USA) using a Cary 60 UV/vis spectrophotometer
and analyzed using WinUV software (Agilent Technologies,
Wokingham, Berkshire, UK). No differences in spectral changes
were observed whether SNAP was incubated with sulﬁde in the
presence or absence of DTPA (100 mM), indicating that transition
metal contamination of our buffers was negligible.
Sulﬁde/disulﬁde nitrosation on solid phase
A stationary nitrosothiol (RSNO) column was prepared using
batch nitrosation of the thiol-containing resin, Ekathiol (Sigma-
Aldrich; Lot 115H1121) in a small beaker. Brieﬂy, 0.4 g dry resin
was suspended in and washed extensively with ultrapure water
before reduction of resin-bound sulfhydryl groups (0.71 mmol
thiol/g resin) with a 10-fold molar excess of dithiothreitol (in
0.01 M NaOH) for 5 min at RT; thereafter, the reductant was
removed by 5 successive washes with ultrapure water. Free
sulfhydryl groups were nitrosated by addition of acidiﬁed nitrite
(NaNO2 in 1 M HCl; 2-fold molar excess), and allowed to react for
30 min at 4 1C in the dark. After a minimum of 5 washing steps
with 10 ml ice-cold ultrapure water, the resin was equilibrated to
pH 8.0 with 100 mM phosphate buffer and ﬁlled into two Pasteur
pipettes with glass wool at the bottom. These mini-columns were
washed 10 times with ice-cold phosphate buffer under dimmed
lighting conditions. Sub-stoichiometric amounts of Na2S or Na2S2
in phosphate buffer were loaded onto the columns and eluted
with ice-cold phosphate buffer; fractions were collected directly
into 1 ml quartz cuvettes and UV–vis spectra recorded using an
Agilent 8453 diode array spectrophotometer and ChemStation
software (Agilent Technologies).
Kinetics of NO release
In situ NO formation from SNAP (1 mM) with/without Na2S
(0.1–10 mM) in the presence or absence of the metal chelator
DTPA (100 mM) in 1 M Tris or 100 mM phosphate buffer, pH 7.4,
was monitored by gas phase chemiluminescence (CLD 77am sp;
Ecophysics, Dürnten, Switzerland) using a custom-designed, water
jacketed glass reaction chamber (15 ml total volume) kept at
2570.1 1C and continuously bubbled with nitrogen. 1 ml volumes
of the respective SNAP/sulﬁde mixtures were premixed in Eppen-
dorff vials, vortexed, and at the indicated time interval of incuba-
tion a 25 ml aliquot of the reaction mixture was transferred into the
reaction chamber containing 15 ml buffer (dilution 1: 600) by
means of a gas-tight syringe. NO concentration in the sample gas
was recorded continuously and peak areas were integrated using
an EPC-500/PowerChrom data processing system (eDAQ; Red Box
Direct, Dublin, Ireland).
Oxygen consumption measurements
Changes in dissolved oxygen concentration in incubation mix-
tures of SNAP and sodium sulﬁde (in 100 mM phosphate buffer pH
7.4, as above) were monitored polarographically using a dual
channel Clark-type electrode system (Digital Model 20; Rank
Brothers Ltd, Cambridge) and LabChart (ADInstruments, Oxoford,
UK); incubation volume was 3 ml; solutions were maintained at a
constant temperature of 3770.5 1C using a circulating water bath.
Reactions were typically started by the addition of SNAP to
prewarmed sulﬁde-containing buffer solutions while continuously
stirring, although the sequence of addition of sulﬁde or nitro-
sothiol did not have any effect on measured rates of oxygen
consumption.
Statistical analysis
Data are reported as means7SEM. ANOVA followed by an
appropriate post hoc multiple comparison test (Tukey or Student0s
T test) was used to test for statistical signiﬁcance.
Results
Sulﬁde modulates nitrosothiol bioactivity in a concentration-
dependent manner
Nitrosothiols are known to activate and modulate sGC activity
in vascular tissue and a wide variety of cellular preparations
[32–34]. In this study, potential changes in nitrosothiol bioactivity
by sulﬁde were investigated by analyzing SNAP-induced sGC
activation in RFL-6 cells, a convenient NO reporter system lacking
an active NO synthase and expressing low levels of PDE5 [31].
Total PDE activity in RFL-6 cells was found to be greater for cAMP
than cGMP (295715 vs. 129714 pmol/mg/min, p10; n¼2) and
decreased on further passaging (11178 vs 8173 pmol/mg/min,
p17; n¼2). To minimize the effects of cell passage-dependent and
sulﬁde-induced variations in PDE activity on intracellular cGMP
levels, experiments were carried out in the presence of IBMX.
Using this system we found that sulﬁde modulates the NO
bioactivity of SNAP to varying degrees, depending on the relative
concentration ratio of sulﬁde over SNAP. Low sulﬁde concentra-
tions (1–10 mM) inhibited sGC stimulation by 100 mM SNAP
(Fig. 1A), whereas cGMP levels with equimolar concentrations of
sulﬁde and SNAP were not different from those of SNAP alone
(Fig. 1A). Similar results were obtained when intracellular sulﬁde
levels were elevated by pre-incubating cells with the sulﬁde donor
GYY4137. Pre-incubation with 10–100 mM GYY4137 increased
intracellular ﬂuorescence of the sulﬁde-speciﬁc probe WSP-1
(Fig. S1B) and inhibited SNAP-induced cGMP increases (Fig. 1B)
in a concentration-dependent fashion. Unexpectedly, we found
that high concentrations of sulﬁde (100 mM Na2S or 1 mM
GYY4137) increased cGMP even in the absence of SNAP (Fig. 1A
and C). These sulﬁde-mediated cGMP increases were inhibited by
either cPTIO or ODQ, but unaffected by the presence/absence of
IBMX (Fig. 1C and D), indicating that the cGMP changes observed
were NO/sGC-dependent but independent of PDE activity.
Whether or not preformed NO-storage pools may account for this
effect of sulﬁde warrants further investigation. SNAP-induced sGC
activation was abolished by treating cells with the sGC inhibitor
ODQ or the NO scavenger cPTIO (see Fig. 1D), indicating that
effects were dependent on the release of NO with consecutive
activation of sGC. Taken together, these results show that low
concentrations of sulﬁde attenuate SNAP bioactivity whereas sGC
stimulation by SNAP is fully restored at equimolar sulﬁde levels.
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The reaction of sulﬁde with nitrosothiols leads to formation of more
than one NO-releasing species
In order to characterize the chemical biology of interaction
between SNAP and sulﬁde, we monitored the reaction using time-
resolved UV/vis spectrometry and gas phase chemiluminescence
(Fig. 2). SNAP decomposition (decrease in λmax at 340 nm) was
accompanied by absorbance increases in the region of 250–
300 nm and 390–430 nm with a peak at λmax 412 nm (Fig. 2A
and B), and – under some conditions – transiently around 320 nm
(Figs. 2 and 3A), indicative of the formation of multiple reaction
products/intermediates. Nature, yield, rate of formation, and
stability of these products were strictly dependent on the con-
centration ratio of the reactants (see Fig. 2A and B). Similar
spectral changes, albeit with different kinetics, were observed
when sulﬁde was allowed to react with two other nitrosothiols,
CysNO and GSNO (Figs. S2A, S2B). To investigate the potential of
reaction products to generate NO after complete decomposition of
the starting material, aliquots of the reaction mixture of SNAP and
sulﬁde were subjected to chemiluminescence analyses at different
time points of co-incubation.
Transition metals in aqueous buffers can trigger nitrosothiol
decomposition [35]; in our hands, SNAP alone produced a very
small NO signal when experiments were carried out in the
presence of the metal chelator DTPA (100 mM; Fig. 2C and D).
However, peak NO release was markedly enhanced when SNAP
was pre-incubated for 1 min with sulﬁde prior to injection into the
reaction chamber (Fig. 2C). This enhancement of rate of NO
formation was apparent at sub-stoichiometric concentrations of
sulﬁde and became progressively more prominent as sulﬁde
concentrations increased (1:1, 1:2, 1:5 and 1:10), seemingly
matching the extent of formation of the 412 nm peak (Fig. 2A). A
biphasic NO release proﬁle was observed at higher sulﬁde
concentrations, with a sharp initial peak followed by a more
sustained lower level of NO production. Injection of aliquots of
the reaction mixture that had been pre-incubated for 10 min
revealed a decreased NO releasing capacity (Fig. 2D), indicative
of ongoing decomposition of NO-generating entities. The long-
lasting NO releasing component was observed only at higher
sulﬁde concentration ratios. Since SNAP itself produces just traces
of NO under these conditions (and the absorbance feature at
340 nm rapidly disappears on incubation with excess sulﬁde), the
NO formation we detected could not have originated from SNAP
itself; thus other products capable of releasing NO must have been
formed in the course of the reaction.
Fig. 2. The reaction between sulﬁde and nitrosothiols leads to formation of NO-releasing species. (A,B) UV–visible spectroscopic analyses of the reaction between SNAP and
hydrosulﬁde at pH 7.4. Varying SNAP/Na2S concentration ratios lead to formation of different products as assessed after 1 min (A) and 10 min of incubation (B); with excess
sulﬁde accumulation of a ‘yellow compound’ (λmax 412 nm) was observed. (C,D) Proﬁles of NO release from SNAP/Na2S mixtures of different concentration ratios after 1 min
(C) or 10 min of incubation (D). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. Oxygen consumption by the reaction of SNAP with sulﬁde. Changes in
dissolved oxygen (O2) concentration in air-saturated phosphate buffer pH 7.4 by
1 mM SNAP (green tracing) or 2 mM Na2S alone (yellow), as compared to mixtures
of 1 mM SNAP and different concentration of sulﬁde (1, 2, 10 mM, ﬁnal concentra-
tions). Representative tracings of 3–4 separate runs at each condition yielding
qualitatively identical results. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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Nitrosothiol/sulﬁde reactions are accompanied by the consumption
of oxygen
Solutions of either NO or sulﬁde are known to slowly react with
oxygen (autoxidation) [2,8]. In order to investigate whether the
chemical interaction of sulﬁde with nitrosothiols affects the
concentration of dissolved oxygen beyond that expected by the
sum of either reactant alone we monitored oxygen consumption in
SNAP/sulﬁde incubation mixtures. As depicted in Fig. 3, oxygen
consumption rates accelerated dramatically on coincubation of
SNAP and sulﬁde, exceeding that of either reaction partner by
orders of magnitude. Although higher molar ratios of sulﬁde over
SNAP tended to hasten oxygen consumption compared to equi-
molar levels no simple concentration dependence was apparent,
with well-behaved second/pseudo ﬁrst order rates adopting a
biphasic kinetic proﬁle whenever sulﬁde was in excess over SNAP.
Such changes are difﬁcult to rationalize by a simple enhancement
of NO production alone but consistent with the formation of more
reactive radical intermediates.
A ‘yellow compound’ is produced by reaction of nitrosothiols with
excess sulﬁde and assigned to be nitrosopersulﬁde, SSNO
A major product of the reaction of SNAP (and other nitro-
sothiols, as demonstrated for CysNO and GSNO in Figs. S2A, S2B)
with excess sulﬁde consists of a ‘yellow compound’ with a strong
absorbance feature at 412 nm (Fig. 2A and B; Fig. 4A and B).
Earlier work by Seel et al. [36] and Munro et al. [37] had
described the formation of a similar absorbance feature with a
maximum at 409–410 nm in the course of the reaction between
sodium sulﬁde and NO or nitrosothiols, respectively; those
experiments had been carried out in unbuffered strongly alkaline
solutions, and both groups had attributed this peak to the
formation of the stable yellow-colored nitrosodisulﬁde (perthio-
nitrite) anion, SSNO . Our own experiments conﬁrmed that the
absorption maximum of the ‘yellow compound’ shows a small
bathochromic shift on further alkalinization. When the reaction
of SNAP and sulﬁde was carried out in polar organic solvents such
as DMSO (Fig. 4C) or DMF (not shown) the absorbance maximum
shifts to 448 nm, again consistent with observations by Seel et al.
[38]. Under these conditions, another prominent absorbance
feature with a maximum at 330 nm occurs (Fig. 4C). According
to Seel et al. [38], this peak is indicative of the formation of
thionitrite (SNO). The formation of either species was observed
also when sulﬁde was reacted with the classical nitrosating
agent, isopentyl nitrite (IPN), instead of SNAP; in this case, SSNO
formation was less pronounced and clearly preceded by the
formation of SNO (Fig. 4D).
The reaction between sulﬁde and nitrosothiols was also carried
out on solid phase by passing aqueous solutions of sulﬁde (0.1, 0.5,
2 mmoles in 100 ml of 100 mM phosphate buffer, pH 8) over a resin
containing immobilized S-nitrosothiol moieties serving as a sta-
tionary nitrosonium (NOþ) donor (Fig. 5). The higher concentra-
tion of sulﬁde produced a faint yellow band in the upper part of
the packed resin that turned intensely yellow/orange on migrating
down the column; this was accompanied by the formation of gas
bubbles. The lower and medium concentrations of sulﬁde pro-
duced a step-like absorbance feature in the UV range, indicative of
the formation of polysulﬁdes. The absorption spectrum of the
yellow eluate collected from the high sulﬁde fraction revealed a
broad symmetrical peak between 320 and 500 nm (λmax 412 nm).
An identically colored solution with a peak absorbance at 412 nm
was obtained when sodium disulﬁde (Na2S2) instead of Na2S
solutions were passed over the column.
Fig. 4. Formation of SNO and SSNO during the reaction of SNAP or isopentyl nitrite (IPN) with hydrosulﬁde (HS) under aqueous and non-aqueous conditions. (A,B)
Reaction of Na2S and SNAP in phosphate buffer (PB) at pH 7.4. Green line, starting spectrum of SNAP. Attributions: λmax 320 nm¼SNO; λmax 412 nm¼SSNO (C) Reaction of
Na2S and SNAP in DMSO. Spectra taken in the ﬁrst 60 s after the beginning of the reaction are shown. Attributions λmax 448 nm¼SSNO (D) Reaction of isopentylnitrite (IPN)
with Na2S in DMSO. Red line, starting spectrum of IPN. Attributions: λmax 325 nm¼ONS; λmax 448 nm¼SSNO . Time interval for spectra: 0–60 s. Cycle time 0.1 s. Insets in
(A–D) are depicting the time course of absorbance changes at 412 nm (A,B) or 448 nm (C,D).
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NO release from nitrosopersulﬁde accounts for sustained sGC
activation by SNAP
The peak at λmax 412 nm assigned to SSNO was found to be
rather stable at physiological pH (t1/24430 min at RT; Fig. 6A,
inset). Given this anionic compound is formally a nitrosothiol we
were surprised to see that its lifetime was seemingly unaffected by
the presence of excess sulﬁde and/or addition of other reduced
thiols (tested for glutathione and cysteine, both at 1 mM; Fig. S3).
Addition of a strong base (NaOH) did not affect the stability of this
substance either (Fig. S3), but acidiﬁcation led to immediate
disappearance of the yellow color with its absorbance feature at
412 nm, followed by formation of a colloidal suspension indicative
of sulfur extrusion (not shown). By contrast, decomposition of the
‘yellow compound’ at physiological pH leads to formation of
polysulﬁdes (Fig. S4), which are susceptible to decomposition
following reaction with dithiothreitol (DTT, 1 mM); no precipita-
tion of sulfur was observed in the presence of excess sulﬁde.
Evidence for NO production during SSNO decomposition was
obtained using SNAP/Na2S (1 mM/10 mM) mixtures that were pre-
incubated for at least 10 min, and strongly diluted prior to testing
by gas phase chemiluminescence (Fig. 6A and B; dilution 1:600)
and sGC activation in RFL-6 cells (Fig. 6C and D; 1:5 to 1:500
dilution). Repeated injections of small 25 ml aliquots of the reaction
mixture allowed the determination of an apparent ‘half-life of the
NO releasing activity’ of the reaction products; as observed with
the 412 nm peak (Fig. S3), the decomposition of the SSNO
speciﬁc portion of the NO peak occurred over a similar timescale
(Fig. 6A and B). Parallel investigations of the SNAP/sulﬁde reaction
mixture revealed a concentration-dependent increase in cellular
cGMP levels in RFL-6 cells (Fig. 6C and D). Importantly, sGC
activation by SSNO was considerably more pronounced than
that seen with SNAP (or sulﬁde) alone (Fig. 6C,D), blocked by
addition of the NO scavenger cPTIO and the sGC inhibitor ODQ
(Fig. 6D). Removing excess sulﬁde by zinc precipitation immedi-
ately before addition of the preincubated SNAP/sulﬁde mixture to
the cells had either no effect on or slightly enhanced sGC activa-
tion by SSNO (Fig. 6D).
Discussion
We here demonstrate that 1. sGC stimulation by nitrosothiols is
modulated by variation in extracellular and intracellular sulﬁde
levels; 2. chemical reaction of sulﬁde with nitrosothiols leads to
distinct products, depending on the concentration ratio of the
reactants; 3. with excess sulﬁde over nitrosothiols this reaction
leads to formation of a stable ‘yellow compound’ which we assign
to be nitrosopersulﬁde (SSNO); and 4. SSNO decomposition
generates enhanced NO bioactivity over that of SNAP alone. 5.
Given that sulﬁde concentrations likely exceed those of nitro-
sothiols in most biological compartments, our data suggest that
SSNO is formed whenever NO and H2S are co-generated and
interact, thus contributing to the biological activity of both
“hydrogen sulﬁde” and nitrosothiols. Considering the apparent
stabilities of thionitrite (SNO) and nitrosopersulﬁde in the pre-
sence of reduced thiols (incl hydrosulﬁde), the latter rather than
the former is likely to account for the sustained NO bioactivity of
nitrosothiols. Taken together, our studies imply that SSNO is a
new signaling entity with the potential to generate both NO and
polysulﬁdes.
Chemistry of formation and decomposition of nitrosopersulﬁde
One of the most interesting aspects of our present studies
relates to the observation that a ‘yellow compound’ is formed and
accumulates whenever sulﬁde is in excess over nitrosothiols. On
the basis of its spectral characteristics, and in agreement with
work by Seel and Wagner [36,38] as well as Munro and Williams
[37], we assign this product to be nitrosopersulﬁde (SSNO), a
hybrid species containing a sulfane sulfur and a nitrosonium
moiety attached to opposite ends of a sulfur atom. It formally
belongs to the group of polysulﬁdes (Sx2) and is its smallest
NO-containing representative. Such a compound would seem to be
of particular interest in the context of the cross-talk between the
NO and the H2S signaling pathways, an area of research that has
attracted much interest lately, due to its propensity to generate
both, NO and polysulﬁdes/sulfane sulfur; the latter are becoming
increasingly recognized as potent bioactive sulﬁde metabolites
[39,40].
In the absence of transition metals or light, the homolytic
decomposition of nitrosothiols (RSNO) to yield NO and a thiyl
radical (Eq. 1) is a fairly slow process because the S–N bond is
relatively strong [41].
RSNO-RSþNO ð1Þ
However, nitrosothiols are unstable in the presence of reduced
thiols. The expected reaction between a nitrosothiol and hydro-
sulﬁde, the smallest thiol and one of the strongest nucleophiles of
physiological relevance, is transnitrosation to give thionitrous acid,
a well-established if unstable species [42](Eq. 2).
RSNOþHS-RS þHSNO ð2Þ
ONSS-
NO+SH
SH
SH
SNO
SNO
SNO
ONSS-
HS-
HSS-
Fig. 5. Formation of SSNO from the reaction between sulﬁde and immobilized
S-nitroso moieties. (A) S-nitrosation by acidiﬁed nitrite of resin-bound sulfhydryl
(–SH) groups (Ekathiols) to form an immobilized nitrosothiol. (B,C) A solution of
either Na2S (B) or Na2S2 (C) is passed over the column and reacts with immobilized
S-nitrosothiols to form SSNO (λmax 412 nm; high sulﬁde concentration) and
polysulﬁdes (o280 nm; lower sulﬁde concentrations). Depicted results are repre-
sentative of 4 independent experiments with different batches of nitrosated thiol-
containing resin and various absolute amounts of sulﬁde (0.015–5 mmoles on
column).
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Transnitrosation is a rapid reaction, and all of the HS should be
converted into HSNO. Assuming a pKa for the latter similar to that
of nitrous acid (HONO), at physiological pH this species is expected
to exist largely in the form of the corresponding anion, thionitrite
(SNO); in alkaline solution, thionitrite has an absorption max-
imum near 320 nm [43,44], which corresponds to one of the
transient spectral features we observed in the present study (see
Figs. 2 and 3).
Nitrosothiols act as vasodilators because of their ability to
donate NO to sGC. HSNO might be expected do the same but,
because of the mobile hydrogen in the molecule, it can undergo a
number of other reactions, such as facile isomerization to three
other species with the same formula (HNSO, HOSN, HSNO, HONS
and their corresponding anions, respectively; (Eq. 3) [25]).
HNSO⇌HOSN⇌HSNO⇌HONS ð3Þ
Although the decomposition products of these species have not
been investigated in great detail, they appear to be largely gaseous
and/or form polymeric material [45]. Thus, HSNO will not deliver
to sGC a stoichiometric amount of NO, as does RSNO. As a result,
formation of HSNO/SNO results in reduced stimulation of sGC.
In the presence of higher concentrations of HS the situation is
rather different as another reaction (nucleophilic attack of HS)
becomes dominant.
HSNOþHS-HSSHþNO ð4Þ
HSSH⇌Hþ þHSS ð5Þ
This is a second order reaction (rate¼k[HSNO][HS]) and so, while
negligible at low concentrations of HS , at higher hydrosulﬁde
concentrations it dominates. The persulﬁde (hydrodisulﬁde anion;
HSS) formed is also a strong nucleophile; it can undergo
transnitrosation with RSNO in a fashion similar to HS .
RSNOþHSS-RSHþSSNO ð6Þ
The resulting nitroso compound, nitrosopersulﬁde (perthionitrite;
SSNO) appears, from our work and that of Seel et al. [36,43], to be
considerably more stable than HSNO and, therefore, a better
vasodilator. The formation of sulfur chains, admittedly a chain of
only two in this instance, is so common in sulfur chemistry that to
ﬁnd evidence for the long-term presence of HSNO would be
surprising. Longer sulfur chains are common at higher concentra-
tions, and elemental sulfur exists, of course, as S8. It is not
unreasonable to postulate that, because of its enhanced stability,
HSSNO/SSNO is better able to provide sGC with NO. At the same
time it is more mobile than RSNO and therefore a more versatile
vasodilator. Some of the NO moiety is lost as nitroxyl anion, NO
(Eq. 4), but vascular tissue can readily convert this to NO [46].
Thus, high concentrations of HS enhance the vasodilator activity
of nitrosothiols.
Alternative routes to nitrosopersulﬁde formation may exists
when thiol disulﬁdes (RSSR’) are present; in this case, alkyl
persulﬁdes (RSS) may be formed [47], which may serve as a
source of HSS (Eqs. 6,7).
RSSR0 þHS-RSSHþR0S ð7Þ
Fig. 6. Decomposition of SSNO releases NO and activates of sGC. (A) UV–visible spectra (main panel) and chemiluminescent proﬁle of NO release (inset) of a SNAP/Na2S
mixtures (1:10) at pH 7.4 following 1 min (gray) or 10 min (orange) of incubation at RT in 1 M TRIS buffer, pH 7.4. (B) Original chemiluminescence tracing of NO release over
time of a SNAP/Na2S mixture (1:10) incubated for the indicated time points. Inset: changes in total NO release (area under the curve) with increasing time of preincubation.
(C) Dose-dependent sGC activation by the SNAP/Na2S mixture (1:10) incubated for 10 min (SSNO mix) compared to the same volumes of a control mix prepared with SNAP
only (SNAP mix). (D) NO and sGC dependent cGMP increase in RFL-6 cells after incubation with 20 ml of the SSNO mix compared to the effects of SNAP and sulﬁde (Na2S)
alone. “þZn2þ” denotes removal of excess sulﬁde by zinc precipitation; indicated volumes were added directly to the cell culture medium to reach a total volume of 1 ml.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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RSSHþHS-RS þHSSH ð8Þ
Nitrosopersulﬁde may also be formed via a radical pathway that
starts with the homolytic cleavage of HSNO to generate sulfanyl
(hydrosulﬁde radical, HS), which is extremely reactive and
immediately reacts with excess thiolate (in this case, HS) to form
the hydrodisulﬁde radical (HSS).
HSNO-HSþNO ð9Þ
HSþSH-HSS ð10Þ
This species then either reacts further with NO (to form nitroso-
persulﬁde; Eq. 11) or oxygen (to form superoxide; Eq. 12).
HSS þNO-HSSNO⇌SSNO þHþ ð11Þ
HSS þO2-HSS þO2 ð12Þ
Thus, SSNO might form via several different avenues [37].
Formation via HSNO seems a plausible route, since isopentyl
nitrite (a prototypical nitrosating agent characterized by an alkyl
nitrite (R-ONO) grouping) was demonstrated here to undergo a
similar reaction in that it ﬁrst leads to SNO generation, with
SSNO formation becoming apparent only much later (Fig. 4D).
Those experiments were carried out in DMSO (as shown here) and
DMF. The advantage of using these non-aqueous ‘electron pair
donor’ solvents is that under these conditions, anions exist
essentially in their “naked” form (unlike in water where solvation
is via formation of hydrogen bonds), resulting in an enhancement
of their nucleophilicity. In the case of SSNO , a large bathochromic
shift from 412 nm (in aqueous solution) to 450 nm is observed; for
SNO a lesser shift was apparent but a marked enhancement of
molar UV-absorbance was seen. In DMSO/DMF one can also
observe the vibrational ﬁne structure of the R-ONO absorbance
feature superimposed onto the broad nitrite peak while allowing
for convenient monitoring of the formation of SNO and SSNO at
the same time. The same characteristic changes take place when
the reaction of nitrosothiols with HS is carried out in those
solvents, as we here demonstrate for SNAP and sulﬁde (compare
Fig. 4A with 4C). Interestingly, the same ﬁnal reaction product was
formed when aqueous solutions of either Na2S or Na2S2 were
passed over a stationary nitrosothiol column (Fig. 5). Thus, the
above routes are neither mutually exclusive, nor may they repre-
sent the only pathways through which SSNO can be formed.
Conceivably, multiple reaction pathways may occur in parallel,
which would explain the complexity of spectral interconversions
taking place (as becomes apparent when one analyzes sequential
spectra of reaction mixtures and their absorbance-time records).
The products of SSNO decomposition are NO and polysulﬁdes
as evidenced in the present study by the measurement of gas
phase chemiluminescence and sGC activation (Fig. 6) and the
spectral step-like absorbance features in the UV range character-
istic of polysulﬁdes (Figs. 2, 4 and 5 and S4). As expected, the
potential of SNAP/HS mixtures to release NO correlated inversely
with their peak absorbance at 412 nm, and as SSNO decomposes,
polysulﬁde absorbance at 290–300 nm increases (Fig. S4).
SSNO-SS þNO ð13Þ
SS-S4
2--ðSx2 Þ-H2OSðx1Þ2 þH2S ð14Þ
Assuming homolytic cleavage of SSNO , the most likely initial
product formed in addition to NO is the disulﬁde radical, SS (Eq.
13). Dimerization and reaction with excess thiolate may give rise
to formation of higher polysulﬁdes (Sx
2 /HSx). In aqueous
solutions at pH 7.4, this is followed by hydrolysis and dispropor-
tionation reactions, yielding polysulﬁdes of varying chain lengths
in addition to free H2S [48] (Eq. 14).
What emerges from the above is that the reaction between
nitrosothiols and sulﬁde is all but straightforward; this had already
been observed by others before. Although carried out in unbuf-
fered alkaline solutions rather than at physiological pH (and thus
not directly comparable to the present observations at physiolo-
gical pH), Munro et al. reported that the absorbance changes they
observed at low sulﬁde concentrations were “not easily inter-
preted, and too complicated for a simple kinetic analysis,” possibly
due to “several rapid processes … occurring” [37]. Indeed, the
complexity of the UV/vis spectral changes seen during the reaction
of nitrosothiols with sulﬁde at different concentration ratios
demonstrate that the stability and nature of the intermediates
formed strongly depend on the relative concentration ratio of the
reactants, with thionitrite, nitrosopersulﬁde and NO likely not the
only products formed in this reaction.
What exactly accounts for the scavenging of NO – as indicated
by the inhibition of SNAP-induced cGMP production in RFL-6 cells
– is unclear at present. Similar functional results have been
reported by Moore and coworkers using other NO-donors [10,21]
but – to the best of our knowledge – this is the ﬁrst time that an
inhibition of NO bioactivity has been demonstrated for nitro-
sothiols. While the isomerization tendency of HSNO to form other
products with lower NO generating potential likely plays a role, it
is possible that additional NO-scavenging effects by reactive
sulfur-oxy intermediates such as sulﬁte [49] or sulfur radical
species are involved; the latter could either produce reactive
oxygen species that scavenge NO by direct chemical reaction or
act as temporary “NO sink” by forming S-nitroso species (with the
potential to release NO further downstream, as demonstrated here
for SSNO). Attempts to mechanistically investigate the possible
involvement of radical intermediates by using spin traps i.e. DMPO
would be of little help in this context as they will also trap NO and
thus by deﬁnition lower NO bioavailability. Yet, if thiyl radical
chemistry was indeed involved the nitrosothiol/HS interaction
should also be accompanied by a reaction with “mother nature’s
spin trap”, molecular oxygen. In fact, our own preliminary inves-
tigations (Fig. 3) conﬁrm that dissolved oxygen is consumed upon
reaction of SNAP with sulﬁde at rates exceeding those of either NO
and sulﬁde autoxidation by far. This observation is interesting not
only from a chemical perspective, but also because mitochondrial
sulﬁde oxidation has been linked to physiological oxygen sensing
[50]. The reaction of nitrosothiols with sulﬁde would seem to add
an interesting “twist” to that story. Thus, both the oxygen
dependence of the reaction and the mechanism accounting for
the drop in NO bioavailability at lower sulﬁde concentrations
would seem to merit further investigation.
Effects of sulﬁde on nitrosothiols bioactivity – is it all in the
chemistry?
A series of recent investigations suggests that much of the H2S/
NO cross-talk in the vasculature occurs via modulation of cGMP
breakdown following inhibition of PDE activity [28,51,52]. Con-
sistent with this notion, the PDE5 inhibitor sildenaﬁl has been
shown to attenuate the vasorelaxant effects of NaHS in rat aorta
[51]. In rat smooth muscle cells, treatment with IBMX led to an
increase in cGMP whereas sulﬁde itself had little effect [28]. While
sulﬁde was unable to directly activate isolated sGC or modify sGC
stimlation by the NO donor DEA/NO [52], low concentrations of
sulﬁde were found to inhibit cellular PDE preparations [28] and
recombinant PDE5 [51]. However, these results are not without
controversy as others, using the endothelial cell line RF/6A, failed
to demonstrate a cGMP increase by sulﬁde [53].
We ﬁnd that sulﬁde-mediated cGMP elevations in RFL-6 cells
were inhibited by ODQ and unaffected by the presence of IBMX
indicating that these effects are dependent on sGC activity, i.e. the
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formation of cGMP rather than alterations in outward transport or
enzymatic breakdown. Consistent with earlier reports [54], IBMX
alone did not affect basal cGMP levels in RFL-6 cells, presumably as
these cells do not have an active NO-synthase and express only
low levels of PDE5 [29]. Accordingly, we did not observe any
difference in SNAP-induced cGMP elevations from baseline in the
presence or absence of IBMX; moreover, the cGMP-speciﬁc PDE
activity of these cells was lower than the corresponding cAMP-
related activity. Interestingly, the NO scavenger cPTIO signiﬁcantly
attenuated sGC activation by higher sulﬁde concentrations but had
no effect on basal levels. This action proﬁle is consistent with the
notion that sulﬁde may contribute to sGC activation following
direct chemical interaction with NO stores, although this possibi-
lity has not been experimentally veriﬁed. Taken together, the
effects of sulﬁde on intracellular cGMP levels appear to be
dependent on the interplay between cGMP production by sGC,
cyclic nucleotide breakdown and possibly clearance pathways
(e.g., alterations in cyclic nucleotide transport across membrane).
If true, this might explain why responses to sulﬁde differ between
cell type and vascular beds studied.
Physiological relevance of the sulﬁde/nitrosothiol interaction
The potential of hydrosulﬁde (and by inference, H2S) to either
attenuate or potentiate NO bioactivity may be of relevance to the
regulation of vascular tone. From studies in rodent tissue we know
that nitrosothiols, an important storage form of NO [55,56], are
particularly abundant in the vasculature [56]; the same seems to
hold true for sulﬁde-related metabolites (at least in the aorta [57]),
and both, endothelial and smooth muscle cells have been shown
to express the enzymatic machinery capable of generating H2S
[19,58,59]. Sulﬁde may therefore contribute to the ﬁne-tuning of
NO bioactivity in the vasculature, either via modulation of intra-
cellular cGMP concentrations following inhibition of PDE activity
[28,51,52] and/or, as demonstrated in the current study, by
chemically reacting with nitrosothiols. Besides the transient for-
mation of SNO , the two major bioactive intermediates produced
in the course of the latter reaction appear to include nitrosoper-
sulﬁde and polysulﬁdes. The concentrations used in the present
proof-of-principle studies are clearly well outside the physiologi-
cally relevant range. Nevertheless, the effects of sulﬁde on SNAP-
induced cGMP accumulation in RFL-6 cells, as shown in Fig. 1,
suggest this interaction can occur also within cells; at present, this
is mere speculation awaiting experimental conﬁrmation by NMR
and/or mass spectrometry based analytical techniques that allow
unequivocal identiﬁcation of SSNO formation in cells and tissues.
However, since the outcome of this chemical cross-talk is strongly
dependent on the relative concentration ratio of the reactants and
linked to oxygen availability in several ways, in vivo experiments
will ultimately be required to shed further light on the biological
relevance of this interaction. The situation may be considerably
more complex under pathophysiological circumstances as the
kinetics of expression of the different enzymes required to sustain
an enhanced production of both H2S and NO likely diverges over
the time-course of induction in different tissue compartments,
giving rise to an interesting dynamic in what already looks like a
complex interaction scenario under controlled conditions. The
present observations may also help explain some of the conﬂicting
results regarding the NO/sulﬁde interaction obtained by different
investigators.
Conclusion
In summary, we have demonstrated that the chemical reaction
of nitrosothiols with sulﬁde leads to modulation of their NO-
related bioactivity in a concentration-dependent fashion, giving
rise to inhibition at low and potentiation at higher sulﬁde
concentrations. Spectral evidence demonstrates that under condi-
tions of excess sulﬁde SSNO is formed, which release NO at
higher rate and thus activates sGC more effectively than the
starting nitrosothiol itself. While further detailed study is war-
ranted to identify the chemical nature and biological activity of
other reaction products involved, the chemical and biological
properties of SSNO suggest that nitrosopersulﬁde represents a
new signaling entity at the cross-roads between sulﬁde and NO/
polysulﬁde signaling.
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